top of page
TODAY'S PROBLEM: BREAKTHROUGH THERAPIES. INADEQUATE DELIVERY.
ONCOXOME HAS THE SOLUTION.
.png)
PRECISE ORAL DELIVERY
Targets cancer cells
beyond the liver


NO REPORTED TOXICITY
Patient friendly,
oral administration
TUMOR REDUCTION
& CONTROL
Dose escalation study
in vivo

VERSATILE DELIVERY
SYSTEM
CRISPR Cas9, SiRNA,
mRNA, proteins
A SUPERIOR WAY TO DELIVER NOVEL CANCER THERAPIES
TRADITIONAL DELIVERY SYSTEMS

Poor targeting

Off-target
toxicity
Resistance development

Limited clinical impact
VS
ONCOXOME'S PLATFORM

Natural targeting

Precise delivery to tumor cells

Minimal toxicity/off-target effects

Potent efficacy potential
bottom of page

